Evidence map›Paper›PMID 42125006›Full record

ReviewIJTLD open2026

Mental health management in the context of TB care in the WHO European Region: a consensus statement.

C Vilaplana, O Konstantynovska, O Rzhepishevska, L Codecasa, L Larocca, D Zaçe, B Häcker, R Otto-Knapp, R Duarte, M Pinheiro and 24 more

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in IJTLD open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

34 authors.

C VilaplanaExperimental Tuberculosis Unit, Germans Trias i Pujol Research Institute and Hospital (IGTP), Badalona, Spain.
O KonstantynovskaDepartment of Infectious Diseases and Clinical Immunology, V. N. Karazin Kharkiv National University, Kharkiv, Ukraine.
O RzhepishevskaDepartment of Chemistry, Umeå University, Umeå, Sweden.
L CodecasaSSD Tisiologia Clinica E Preventiva, Centro Regionale di Riferimento per il Controllo della Tubercolosi, Istituto Villa Marelli- ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy.
L LaroccaUnit of Infectious Diseases, Department of Clinical and Experimental Medicine, ARNAS Garibaldi Nesima Hospital, University of Catania, Catania, Italy.
D ZaçeDepartment of Systems Medicine, University of Rome Tor Vergata, Rome, Italy.
B HäckerDZK - German Central Committee Against Tuberculosis, Berlin, Germany.
R Otto-KnappDZK - German Central Committee Against Tuberculosis, Berlin, Germany.
R DuarteEPIUnit, Instituto de Saúde Pública, Universidade do Porto, Porto, Portugal.
M PinheiroPublic Health Unit Barcelos/Esposende, Barcelos/Esposende Health Local Unit, Universidade do Porto, Porto, Portugal.
A AguiarEPIUnit, Instituto de Saúde Pública, Universidade do Porto, Porto, Portugal.
M JankovićSchool of Medicine, University of Zagreb, Zagreb, Croatia.
I A Pérez-HernándezUnidad de Enfermedades Infecciosas, IBIMA-Plataforma BIONAND, Hospital Universitario Virgen de la Victoria, Málaga, Spain.
J P MilletEpidemiology Service, Public Halth Agency of Barcelona, TB Center Serveis Clinics, and CIBER de Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain.
I NordstogaLHL International Tuberculosis Foundation, Oslo, Norway.
M DrageLHL International Tuberculosis Foundation, Oslo, Norway.
A M Dyrhol-RiiseDepartment of Infectious Diseases, Oslo University Hospital, Oslo, Norway.
A DudnykInnovation in Respiratory Infections and Tuberculosis Diagnosis Group, Institut d'Investigació Germans Trias i Pujol (IGTP), Barcelona, Spain.
P FraisseRéseau National des Centres de lutte Antituberculeuse and the GREPI Working Group of the Société de Pneumologie de Langue Française (SPLF), Paris, France.
M Fréchet-JachymCentre Hospitalier de Bligny, Briis-sous-Forges, France.
F-X BlancNantes Université, CHU Nantes, Service de Pneumologie, L'institut du Thorax, Nantes, France.
Z NanovicInstitute for Lung Diseases and Tuberculosis, Skopje, Republic of North Macedonia.
G GüntherDepartment of Pulmonology, Allergology and Clinical Immunology, Inselspital, Bern, Switzerland.
A EichenbergerDepartment of Infectious Diseases, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
S DegtyarevaKrankenhaus St. Raphael Ostercappeln, Germany.
J CallumHomerton University Hospital NHS Foundation Trust, NHS England, University of Sydney, Sydney, NSW, Australia.
M DedicoatDepartment of Infection, University Hospitals Birmingham, Birmingham, UK.
A DumitrescuMarius Nasta Institute of Pneumology, German Centre for Infection Research (DZIF), Eastern European Study Site, Bucharest, Romania.
J BruchfeldUnit of Infectious Diseases, Department of Medicine Karolinska Institute, Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden.
G AugusteTB Center Serveis Clinics, Barcelona, Spain.
D AznarExperimental Tuberculosis Unit, Germans Trias i Pujol Research Institute and Hospital (IGTP), Badalona, Spain.
A LacomaDepartment of Genetics and Microbiology, Universtiat Autònoma de Barcelona, Cerdanyola del Vallès, Spain.
J CuevasDepartment of Psychiatry, Germans Trias i Pujol Research Institute and Hospital and Universitat Autònoma de Barcelona, Catalonia, Spain.
J de PabloDepartment of Psychiatry, Germans Trias i Pujol Research Institute and Hospital and Universitat Autònoma de Barcelona, Catalonia, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIntegrated care for TB and mental health is critical, as mental disorders worsen TB outcomes. WHO guidelines recommend routine screening for mental health conditions and integrated care for TB patients, yet implementation remains uncertain.

methodsWe conducted a survey with the participation of 34 experts from 26 countries from the WHO European Region within TBnet and the ADVANCE-TB COST Action, followed by a Delphi process to assess the uptake of WHO recommendations and build consensus on strategies for integrated TB-mental health care.

resultsThe survey showed substantial gaps: only 21% of experts, representing six countries, reported local or national guidelines integrating mental health into TB care, and systematic screening was rare, including for drug-resistant TB. Building on these findings, the Delphi process reached consensus on the need for validated screening tools at key treatment stages, structured referral pathways, and tighter alignment between TB and mental health services. Eighteen consensus recommendations were developed, addressing training, routine data collection, technology-supported care, and sustainable financing.

conclusionMental health remains insufficiently integrated into TB care across the WHO European Region. Routine screening coordinated referral systems and implementation of the proposed recommendations are essential to deliver people-centred, equitable, and effective TB care.

Indexed as

drug-resistant TBintegrated caremental disordersstigmatuberculosisWHO guidelines

Identifiers

PMID42125006
PMCPMC13160271

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.